Parkman Healthcare Partners »

Compass Pathways shares owned by Parkman Healthcare Partners

Quarter-by-quarter ownership of Compass Pathways (CMPS) shares owned by Parkman Healthcare Partners from 13F filings

Historical chart of Parkman Healthcare Partners investment in Compass Pathways

Tip: Access up to 7 years of quarterly data

All positions including Compass Pathways held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Pathways by Parkman Healthcare Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $573k 100k 5.73

More positions owned by Parkman Healthcare Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation (BSX)
Alnylam Pharmaceuticals (ALNY)
Insulet Corporation (PODD)
CVS Caremark Corporation (CVS)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Miragen Therapeutics (VRDN)
Zimmer Holdings (ZBH)
Stryker Corporation (SYK)
Qiagen Nv Com Shs (QGEN)
McKesson Corporation (MCK)
Danaher Corporation (DHR)
Kalvista Pharmaceuticals (KALV)
Uniqure Nv SHS (QURE)
Neurocrine Biosciences (NBIX)

View all positions for Parkman Healthcare Partners

Top funds holding Compass Pathways

Rtw Investments
Deep Track Capital
GMT Capital Corp
Millennium Management
Tang Capital Management
Ally Bridge Group
UBS Group
ARK Investment Management
Nantahala Capital Management
Partner Fund Management
Leucadia National Corporation
Hsbc Holdings
Ameriprise Financial
Aisling Capital Management
Susquehanna International

View all funds holding Compass Pathways